199 related articles for article (PubMed ID: 23475484)
21. NKT cell responses to glycolipid activation.
Tefit JN; Davies G; Serra V
Methods Mol Biol; 2010; 626():149-67. PubMed ID: 20099127
[TBL] [Abstract][Full Text] [Related]
22. CD1d-Restricted Type II NKT Cells Reactive With Endogenous Hydrophobic Peptides.
Nishioka Y; Masuda S; Tomaru U; Ishizu A
Front Immunol; 2018; 9():548. PubMed ID: 29599785
[TBL] [Abstract][Full Text] [Related]
23. Optimizing NKT cell ligands as vaccine adjuvants.
Carreño LJ; Kharkwal SS; Porcelli SA
Immunotherapy; 2014; 6(3):309-20. PubMed ID: 24762075
[TBL] [Abstract][Full Text] [Related]
24. Ex vivo induction and expansion of natural killer T cells by CD1d1-Ig coated artificial antigen presenting cells.
Webb TJ; Bieler JG; Schneck JP; Oelke M
J Immunol Methods; 2009 Jul; 346(1-2):38-44. PubMed ID: 19446558
[TBL] [Abstract][Full Text] [Related]
25. Application of natural killer T cells in antitumor immunotherapy.
Hong C; Park SH
Crit Rev Immunol; 2007; 27(6):511-25. PubMed ID: 18197797
[TBL] [Abstract][Full Text] [Related]
26. Recognition of β-linked self glycolipids mediated by natural killer T cell antigen receptors.
Pellicci DG; Clarke AJ; Patel O; Mallevaey T; Beddoe T; Le Nours J; Uldrich AP; McCluskey J; Besra GS; Porcelli SA; Gapin L; Godfrey DI; Rossjohn J
Nat Immunol; 2011 Jul; 12(9):827-33. PubMed ID: 21804559
[TBL] [Abstract][Full Text] [Related]
27. Tailored design of NKT-stimulatory glycolipids for polarization of immune responses.
Hung JT; Huang JR; Yu AL
J Biomed Sci; 2017 Mar; 24(1):22. PubMed ID: 28335781
[TBL] [Abstract][Full Text] [Related]
28. Identification of novel glycolipid ligands activating a sulfatide-reactive, CD1d-restricted, type II natural killer T lymphocyte.
Rhost S; Löfbom L; Rynmark BM; Pei B; Månsson JE; Teneberg S; Blomqvist M; Cardell SL
Eur J Immunol; 2012 Nov; 42(11):2851-60. PubMed ID: 22777932
[TBL] [Abstract][Full Text] [Related]
29. Glycolipid activators of invariant NKT cells as vaccine adjuvants.
Kharkwal SS; Arora P; Porcelli SA
Immunogenetics; 2016 Aug; 68(8):597-610. PubMed ID: 27377623
[TBL] [Abstract][Full Text] [Related]
30. Glycolipids injected into the skin are presented to NKT cells in the draining lymph node independently of migratory skin dendritic cells.
Tripp CH; Sparber F; Hermans IF; Romani N; Stoitzner P
J Immunol; 2009 Jun; 182(12):7644-54. PubMed ID: 19494288
[TBL] [Abstract][Full Text] [Related]
31. Structure-activity relationship studies of novel glycosphingolipids that stimulate natural killer T-cells.
Tashiro T
Biosci Biotechnol Biochem; 2012; 76(6):1055-67. PubMed ID: 22790924
[TBL] [Abstract][Full Text] [Related]
32. Human Invariant Natural Killer T Cells Respond to Antigen-Presenting Cells Exposed to Lipids from Olea europaea Pollen.
Abos Gracia B; López Relaño J; Revilla A; Castro L; Villalba M; Martín Adrados B; Regueiro JR; Fernández-Malavé E; Martínez Naves E; Gómez Del Moral M
Int Arch Allergy Immunol; 2017; 173(1):12-22. PubMed ID: 28486236
[TBL] [Abstract][Full Text] [Related]
33. Glycolipids as immune modulatory tools.
Lalazar G; Preston S; Zigmond E; Ben Yáacov A; Ilan Y
Mini Rev Med Chem; 2006 Nov; 6(11):1249-53. PubMed ID: 17100636
[TBL] [Abstract][Full Text] [Related]
34. NKT-cell glycolipid agonist as adjuvant in synthetic vaccine.
Liu Z; Guo J
Carbohydr Res; 2017 Nov; 452():78-90. PubMed ID: 29080431
[TBL] [Abstract][Full Text] [Related]
35. Photoactivable Glycolipid Antigens Generate Stable Conjugates with CD1d for Invariant Natural Killer T Cell Activation.
Veerapen N; Kharkwal SS; Jervis P; Bhowruth V; Besra AK; North SJ; Haslam SM; Dell A; Hobrath J; Quaid PJ; Moynihan PJ; Cox LR; Kharkwal H; Zauderer M; Besra GS; Porcelli SA
Bioconjug Chem; 2018 Sep; 29(9):3161-3173. PubMed ID: 30085659
[TBL] [Abstract][Full Text] [Related]
36. Alterations in cellular metabolism modulate CD1d-mediated NKT-cell responses.
Webb TJ; Carey GB; East JE; Sun W; Bollino DR; Kimball AS; Brutkiewicz RR
Pathog Dis; 2016 Aug; 74(6):. PubMed ID: 27297969
[TBL] [Abstract][Full Text] [Related]
37. Immunotherapeutic strategies targeting natural killer T cell responses in cancer.
Shissler SC; Bollino DR; Tiper IV; Bates JP; Derakhshandeh R; Webb TJ
Immunogenetics; 2016 Aug; 68(8):623-38. PubMed ID: 27393665
[TBL] [Abstract][Full Text] [Related]
38. NKT cells in mucosal immunity.
Middendorp S; Nieuwenhuis EE
Mucosal Immunol; 2009 Sep; 2(5):393-402. PubMed ID: 19587641
[TBL] [Abstract][Full Text] [Related]
39. Structural determination of lipid antigens captured at the CD1d-T-cell receptor interface.
Brennan PJ; Cheng TY; Pellicci DG; Watts GFM; Veerapen N; Young DC; Rossjohn J; Besra GS; Godfrey DI; Brenner MB; Moody DB
Proc Natl Acad Sci U S A; 2017 Aug; 114(31):8348-8353. PubMed ID: 28716901
[TBL] [Abstract][Full Text] [Related]
40. Natural killer T-cell autoreactivity leads to a specialized activation state.
Wang X; Chen X; Rodenkirch L; Simonson W; Wernimont S; Ndonye RM; Veerapen N; Gibson D; Howell AR; Besra GS; Painter GF; Huttenlocher A; Gumperz JE
Blood; 2008 Nov; 112(10):4128-38. PubMed ID: 18779390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
